Cero Therapeutics prices $5M at-the-market offering

CERo Therapeutics (CERO) announced the pricing of its “reasonable best efforts” public offering with participation from a member of the Company’s board and a single institutional investor for the purchase and sale of 2,551,020 shares of its common stock and warrants to purchase up to 2,551,020 shares of common stock at a combined purchase price of $1.96. The warrants will have an exercise price of $1.96 per share, will be immediately exercisable upon stockholder approval and will expire 5 years from the initial exercise date.